Evidence map›Paper›PMID 40494548›Full record

ArticleBrain : a journal of neurology2026

Loss of DOT1L disrupts neuronal transcription and leads to a neurodevelopmental disorder.

Marissa J Maroni, Melissa Barton, Katherine Lynch, Ashish R Deshwar, Philip D Campbell, Josephine Millard, Rachel Lee, Annastelle Cohen, Rili Ahmad, Alekh Paranjapye and 44 more

Abstract read
In one paragraph

Article in Brain : a journal of neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Neurod2 knockdown inmicroPublication biology · 2026
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

54 authors.

Marissa J MaroniNeuroscience Graduate Group, University of Pennsylvania, Philadelphia, PA 19104, USA.
Melissa BartonDepartment of Genetics, University of Pennsylvania, Philadelphia, PA 19104, USA.
Katherine LynchDepartment of Genetics, University of Pennsylvania, Philadelphia, PA 19104, USA.
Ashish R DeshwarProgram in Developmental and Stem Cell Biology, Sickkids Research Institute, Toronto, ON M5G 0A4, Canada.ORCID 0000-0002-9239-3846
Philip D CampbellDepartment of Psychiatry, University of Pennsylvania, Philadelphia, PA 19104, USA.
Josephine MillardDepartment of Genetics, University of Pennsylvania, Philadelphia, PA 19104, USA.
Rachel LeeDepartment of Biochemistry and Molecular Pharmacology, New York University Grossman School of Medicine, New York, NY 10016, USA.
Annastelle CohenDepartment of Genetics, University of Pennsylvania, Philadelphia, PA 19104, USA.
Rili AhmadDepartment of Genetics, University of Pennsylvania, Philadelphia, PA 19104, USA.
Alekh ParanjapyeDepartment of Genetics, University of Pennsylvania, Philadelphia, PA 19104, USA.
Víctor FaundesLaboratorio de Genética y Enfermedades Metabólicas, Instituto de Nutrición y Tecnología de los Alimentos, Universidad de Chile, Santiago 7830490, Chile.
Gabriela M RepettoRare Diseases Program, Center for Genetics and Genomics, Institute for Science and Innovation in Medicine, Facultad de Medicina, Clínica Alemana-Universidad del Desarrollo, Las Condes 7610671, Chile.
Caoimhe McKennaNorthern Ireland Regional Genetics Service, Belfast BT9 7AB, Northern Ireland.
Amelle L ShillingtonDepartment of Human Genetics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229, USA.
Chanika PhornphutkulDivision of Human Genetics, Rhode Island Hospital, Providence, RI 0290, USA.
Hanne B HoveMember of ERNBond, Rare Diseases Unit, Department of Pediatrics and Adolescent Medicine, Rigshospitalet, Copenhagen University Hospital, Copenhagen 2100, Denmark.
Grazia M S ManciniDepartment of Clinical Genetics, Erasmus MC University Medical Center, GD Rotterdam 3015, The Netherlands.ORCID 0000-0002-1211-9979
Rachel SchotDepartment of Clinical Genetics, Erasmus MC University Medical Center, GD Rotterdam 3015, The Netherlands.
Tahsin Stefan BarakatDepartment of Clinical Genetics, Erasmus MC University Medical Center, GD Rotterdam 3015, The Netherlands.ORCID 0000-0003-1231-1562
Christopher M RichmondGenetic Health Queensland, Royal Brisbane & Women's Hospital, Herston, Queensland 4006, Australia.
Julie LauzonAlberta Children's Hospital, Calgary AB Canada Department of Medical Genetics, Cummings School of Medicine, University of Calgary, Calgary AB T2N 1N4, Canada.
Ahmed Ibrahim Elsayed IbrahimBrody School of Medicine, East Carolina University, Greenville, NC 27834, USA.
Caroline NavaInstitut du Cerveau-Paris Brain Institute-ICM, Sorbonne Université, Inserm, CNRS, Hôpital Pitié Salpêtrière, 75013 Paris, France.ORCID 0000-0003-1272-0518
Delphine HéronDépartement de Génétique, Assistance Publique-Hôpitaux de Paris (APHP) Sorbonne Université, Hôpital Pitié-Salpêtrière, 75651 Paris, France.
Minke M A van AalstDepartment of Clinical Genetics, Erasmus MC University Medical Center, GD Rotterdam 3015, The Netherlands.
Slavena AteminGenetic Medico-Diagnostic Laboratory 'Genica', Sofia 1612, Bulgaria.
Mila SleptsovaGenetic Medico-Diagnostic Laboratory 'Genica', Sofia 1612, Bulgaria.
Iliyana AleksandrovaClinic of Child Neurology, MHATNP 'St. Naum', Medical University Sofia, Sofia 1431, Bulgaria.
Albena TodorovaGenetic Medico-Diagnostic Laboratory 'Genica', Sofia 1612, Bulgaria.
Debra L WatkinsDepartment of Genetics, McMaster Children's Hospital, Hamilton, ON L8N 3Z5, Canada.
Mariya A KozenkoDepartment of Genetics, McMaster Children's Hospital, Hamilton, ON L8N 3Z5, Canada.
Daniel Natera-de BenitoNeuromuscular Unit, Hospital Sant Joan de Deu, Barcelona 08950, Spain.
Carlos OrtezNeuromuscular Unit, Hospital Sant Joan de Deu, Barcelona 08950, Spain.
Berta Estevez-AriasNeuromuscular Unit, Hospital Sant Joan de Deu, Barcelona 08950, Spain.
François LecoquierreDepartment of Genetics and Reference Center for Developmental Disorders, Univ Rouen Normandie, Inserm U1245 and CHU Rouen, Rouen 76000, France.
Kévin CassinariDepartment of Genetics and Reference Center for Developmental Disorders, Univ Rouen Normandie, Inserm U1245 and CHU Rouen, Rouen 76000, France.
Anne-Marie GuerrotDepartment of Genetics and Reference Center for Developmental Disorders, Univ Rouen Normandie, Inserm U1245 and CHU Rouen, Rouen 76000, France.
Jonathan LevyDepartment of Genetics, APHP-Robert Debré University Hospital, Paris 75019, France.
Xenia LatypovaDepartment of Genetics, APHP-Robert Debré University Hospital, Paris 75019, France.
Alain VerloesDepartment of Genetics, APHP-Robert Debré University Hospital, Paris 75019, France.
A Micheil InnesUniversity of Calgary Department of Medical Genetics, Alberta Children's Hospital Research Institute, Calgary, AB T3B 6A8, Canada.
Xiao-Ru YangUniversity of Calgary Department of Medical Genetics, Alberta Children's Hospital Research Institute, Calgary, AB T3B 6A8, Canada.
Siddharth BankaDivision of Evolution, Infection and Genomics, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester M13 9WL, UK.ORCID 0000-0002-8527-2210
Katharina VillDepartment of Pediatric Neurology and Developmental Medicine and LMU Center for Children with Medical Complexity, Dr. von Hauner Children's Hospital, LMU Hospital, Ludwig-Maximilians-University, Munich 80539, Germany.
Maureen JacobInstitute of Human Genetics, School of Medicine and Health, Technical University of Munich, Munich 81675, Germany.
Michael KruerPediatric Movement Disorders Program, Division of Pediatric Neurology, Barrow Neurological Institute, Phoenix Children's Hospital, Phoenix, AZ 85016, USA.
Peter SkidmorePediatric Movement Disorders Program, Division of Pediatric Neurology, Barrow Neurological Institute, Phoenix Children's Hospital, Phoenix, AZ 85016, USA.
Carolina I Galaz-MontoyaPediatric Movement Disorders Program, Division of Pediatric Neurology, Barrow Neurological Institute, Phoenix Children's Hospital, Phoenix, AZ 85016, USA.
Somayeh BakhtiariPediatric Movement Disorders Program, Division of Pediatric Neurology, Barrow Neurological Institute, Phoenix Children's Hospital, Phoenix, AZ 85016, USA.
Jessica L MesterGeneDx, Gaithersburg, MD 20877, USA.
Michael GranatoDepartment of Cell and Developmental Biology, University of Pennsylvania, Philadelphia, PA 19104, USA.
Karim-Jean ArmacheDepartment of Biochemistry and Molecular Pharmacology, New York University Grossman School of Medicine, New York, NY 10016, USA.
Gregory CostainDivision of Clinical and Metabolic Genetics, The Hospital for Sick Children, Toronto, ON M5G 1E8, Canada.ORCID 0000-0003-0099-9945
Erica KorbDepartment of Genetics, University of Pennsylvania, Philadelphia, PA 19104, USA.ORCID 0000-0002-7064-8123

Funding

The Intellectual and Developmental Disabilities Research Center (IDDRC) at CHOP/PennP50HD105354 · NICHD · CHILDREN'S HOSP OF PHILADELPHIA · PI ERIC D MARSH, ROBERT Thomas SCHULTZ · 2021 to 2026
$9.2M
Genomic analysis of the Multiplex, Autozygous Populations in Cerebral Palsy (MAP CP) cohort: a focused approach to a complex diseaseR01NS127108 · NINDS · UNIVERSITY OF ARIZONA · PI Michael C Kruer · 2023 to 2026
$2.6M
The epigenetic encoding of learning and memoryDP2MH129985 · NIMH · UNIVERSITY OF PENNSYLVANIA · PI KORB, ERICA MEGAN · 2021 to 2024
$2.4M
The role of chromatin regulators in neurodevelopmental disordersR01NS134755 · NINDS · UNIVERSITY OF PENNSYLVANIA · PI Erica Megan Korb · 2024 to 2026
$1.7M
The Histone Code of Neuronal Function and DysfunctionR00MH111836 · NIMH · UNIVERSITY OF PENNSYLVANIA · PI KORB, ERICA MEGAN · 2019 to 2021
$745k
Linking epigenetics to electrophysiology using high-throughput microelectrode array-based hardware with simultaneous optogenetic activationS10OD032363 · OD · UNIVERSITY OF PENNSYLVANIA · PI PHILLIPS-CREMINS, JENNIFER ELIZABETH · 2023 to 2023
$259k
The Role of H3K79 Methylation and Dot1L in Neuronal Function and Neurodevelopmental DisordersF31NS129242 · NINDS · UNIVERSITY OF PENNSYLVANIA · PI MARONI, MARISSA · 2023 to 2025
$87k
Alfred P. Sloan Foundation FG-2020-13529Alliance for Research on Schizophrenia and DepressionAzrieli Precision Child Health PlatformBrain and Behavior Research FoundationEsther A. and Joseph Klingenstein FundMedical Research CouncilNationalNational Institute of Neurological Disease and Stroke 1F31NS129242National Institute of Neurological Disease and Stroke NS134755A1NICHD NIH HHS P50 HD105354NIH HHS S10 OD032363NIHR Manchester Biomedical Research Centre NIHR203308NIMH NIH HHS 1DP2MH129985NIMH NIH HHS 1S10OD032363NIMH NIH HHS DP2 MH129985NIMH NIH HHS R00 MH111836NIMH NIH HHS R00MH111836NINDS NIH HHS F31 NS129242NINDS NIH HHS R01 NS127108NINDS NIH HHS R01 NS134755SickKids Research InstituteSimons Foundation
6 · The paper itself

Abstract

Individuals with monoallelic gain-of-function variants in the histone lysine methyltransferase DOT1L display global developmental delay and varying congenital anomalies. However, the impact of monoallelic loss of DOT1L remains unclear. Here, we sought to define the effects of partial DOT1L loss by applying bulk and single-nucleus RNA-sequencing, ChIP-sequencing, imaging, multielectrode array recordings and behavioural analysis of zebrafish and multiple mouse models. We present a cohort of 16 individuals (12 females, 4 males) with neurodevelopmental disorders and monoallelic DOT1L variants, including a frameshift deletion, an in-frame deletion, a nonsense, and missense variants clustered in the catalytic domain. We demonstrate that specific variants cause loss of methyltransferase activity. In primary cortical neurons, Dot1l knockdown disrupts transcription of synaptic genes, neuron branching, expression of a synaptic protein and neuronal activity. Further in the cortex of heterozygous Dot1l mice, Dot1l loss causes sex-specific transcriptional responses and H3K79me2 depletion, including within downregulated genes. Lastly, using both zebrafish and mouse models, we found behavioural disruptions that include developmental deficits and sex-specific social behavioural changes. Overall, we define how DOT1L loss leads to neurological dysfunction by demonstrating that partial Dot1l loss impacts neuronal transcription, neuron morphology and behaviour across multiple models and systems.

Indexed as

Histone-Lysine N-MethyltransferaseNeurodevelopmental DisordersNeuronsAdolescentAnimalsChildChild, PreschoolDisease Models, AnimalFemaleHumansMaleMiceTranscription, GeneticZebrafishDOT1L protein, humanDot1l protein, mouseHistone-Lysine N-MethyltransferaseDOT1LH3K79meneurodevelopmental disorders

Identifiers

PMID40494548
PMCPMC12782159

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.